CA
IMNN icon

Commerzbank Aktiengesellschaft’s Imunon IMNN Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1
Closed -$17K – 1400
2013
Q3 		$17K Buy
+1
New +$14.8K ﹤0.01% 1285

Other funds holding IMNN

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Commerzbank Aktiengesellschaft's IMNN Position: Q4 2013 in Review

Commerzbank Aktiengesellschaft sold out of Imunon (IMNN) in Q4 2013, closing a stake of 1 share — an estimated $17K sold.

Commerzbank Aktiengesellschaft first reported a position in IMNN in Q3 2013 and held it in 1 quarter. The position peaked at $17K in Q3 2013. 25 funds tracked by Wall St. Rank hold IMNN as of Q4 2013.

  • Commerzbank Aktiengesellschaft reported no remaining Imunon position as of Q4 2013 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 1 Imunon share in Q4 2013, an estimated $17K.
  • Commerzbank Aktiengesellschaft first reported a position in Imunon in Q3 2013 and held it in 1 quarter.
  • Commerzbank Aktiengesellschaft's Imunon position peaked at $17K in Q3 2013.
  • 25 funds tracked by Wall St. Rank held Imunon as of Q4 2013.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2013, filed 13 Feb 2014.